MedTrace Logo

Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion

NCT01892423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2022-07-29

No results posted yet for this study

Summary

Human repeat insult patch test to assess the potential for Cetaphil Moisturizing Lotion Daily Advance to induce sensitization to the skin

Conditions

  • Skin Irritation

Interventions

OTHER

Cetaphil Moisturizing Lotion Daily Advance

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • James H Herndon, MD, FAAD

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01892423 on ClinicalTrials.gov